Insys seeks fast cash, Nasdaq listing with IPO
This article was originally published in Scrip
Executive Summary
Insys Therapeutics intends to raise up to $82.8 million in an initial public offering of 4 million shares priced at $16 to $18 each plus the sale of additional shares to meet overallotments; the IPO would move the Phoenix, Arizona-based company to the Nasdaq from the Over-the-Counter market to generate much needed cash from a larger pool of investors.